AltruBio Inc.

AltruBio is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of autoimmune and inflammatory diseases. Their approach leverages immune checkpoint agonism, a unique mechanism that enhances the function of natural pathways to downregulate an overactive immune system. AltruBio's lead product candidate, ALTB-268, is a tetravalent PSGL-1 agonist antibody that is currently in Phase 2 clinical trials for the treatment of ulcerative colitis. The company also has a first-generation antibody, ALTB-168, which has demonstrated promising clinical results in other immune-mediated disorders like psoriasis, psoriatic arthritis, and graft-versus-host disease.

AltruBio's mission is to develop safer and more effective treatments that address the unmet needs of patients with autoimmune and inflammatory diseases. Their team of experts has a strong track record in drug development and commercialization, and the company is committed to translating scientific discoveries into life-changing therapies for patients. AltruBio is headquartered in San Francisco, CA, with a R&D center in Taipei, Taiwan.

AltruBio offers a hybrid and/or flexible work schedule for employees, with the option to work remotely. While the company's headquarters is in San Francisco, employees can work from other locations, but will need to travel to San Francisco for key meetings.

AltruBio offers a competitive compensation package for US employees, which includes base pay, a generous 401K match, stock options, and bonus potential. The company provides excellent health benefits with employer-paid premiums, as well as generous time off, an employee assistance program, life and disability insurance, engaging employee events, individual development opportunities, and a hybrid and/or flexible work schedule.

AltruBio is a clinical-stage biotechnology company dedicated to developing innovative treatments for autoimmune and inflammatory diseases by targeting specific pathways in the immune system. Their mission is to further the understanding of how the immune system works, create safer and more effective therapies for patients with immune diseases, and pioneer innovative solutions in drug development and patient care paradigms.

AltruBio promotes a culture that values innovation, collaboration, and a commitment to improving patient health. They foster an open-minded and supportive environment that encourages creative thinking and rapid execution, aiming to translate scientific discoveries into life-saving medicines. With a focus on scientific excellence, AltruBio creates a workplace where talented individuals can bring their authentic selves, have fulfilling careers, and make a real difference in the lives of patients.

AltruBio values diversity, equity, and inclusion as core principles, recognizing that a diverse workforce strengthens the company and helps them achieve their mission of changing the outcome of human diseases. They believe that everyone should bring their authentic selves to work, have fulfilling careers, and contribute to making a positive impact on patients. As such, they are committed to providing a workplace free from discrimination and harassment based on any protected characteristic, fostering a welcoming and inclusive environment where all employees feel valued and respected.